«Malignant Carcinoid

Below is an extended Malignant Carcinoid patents listing. Click here to return to the Malignant Carcinoid main in depth entry.

Patents :
US Patent No.	Title
7053117	Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
7138370	Specific binding agents of human angiopoietin-2
7144873	Kit for delivering decitabine in vivo
7144876	3,5-Disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
7154002	Histone deacetylase inhibitors
7169801	Histone deacetylase inhibitors
7176234	Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis
7195911	Mammalian cells that have increased proliferative capacity
7199234	Regulatory segments of the human gene for telomerase reverse transcriptase
7205275	Methods of treatment using specific binding agents of human angiopoietin-2
7208477	Treatments for benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases
7135480	Substituted 1-benzoyl-3-cyano-pyrrolo [1,2-a] quinolines and analogs as activators of caspases and inducers of apoptosis
7135464	Method of administering decitabine
7056509	Antibody methods for selectively inhibiting VEGF
7067109	Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids
7071202	Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
7074813	Substituted N'-(arylcarbonyl)-benzhydrazides, N'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof
7078491	Selective binding agents of telomerase
7087726	Anti-interferon-.alpha. antibodies
7101557	Combined tissue factor methods for coagulation and tumor treatment
7105186	Triterpene compositions and methods for use thereof
7112573	Isoflavone and triterpene glycosides from soybeans
7132458	Oxidized carotenoid fractions and ketoaldehyde useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents
7223393	Amphiregulin antibodies and their use to treat cancer and psoriasis
7226927	Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof
7232805	Cobalamin conjugates for anti-tumor therapy
7339042	Gene delivery to tumors
7342046	Gossypol co-crystals and the use thereof
7344829	Methods for detecting the efficacy of anticancer treatments
7358046	Sensitivity test to predict efficacy of anti-cancer therapies
7368129	Amphiphilic materials and liposome formulations thereof
7371727	Methods and compositions for the treatment of gastrointestinal disorders
7375228	Histone deacetylase inhibitors
7378386	Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives
7381825	Histone deacetylase inhibitors
7384909	Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents
7332288	Methods and reagents for the rapid and efficient isolation of circulating cancer cells
7319145	Methylenetetrahydrofolate reductase inhibitors and use thereof
7235674	Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
7247303	Selected antibody CDRs for binding to aminophospholipids
7250416	Azacytosine analogs and derivatives
7250514	Histone deacetylase inhibitors
7256219	Multifluoro-substituted chalcones and analogs as activators of caspases and inducers of apoptosis and the use thereof
7262288	Nucleic acids encoding human telomerase reverse transcriptase and related homologs
7276228	Methods for treating hematological disorders through inhibition of DNA methylation and histone deacetylase
7304036	Methods and compositions for the treatment of gastrointestinal disorders
7317028	Cell differentiation inducer
7317029	3,5-disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
7399884	Histone deacetylase inhibitors

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.